Dr. Christie Ballantyne and Dr. C. Michael Gibson talk about the LDL lowering with an oral PCSK9 inhibitor in patients with familial heterozygous hypercholesterolemia. November 24, 2025 Uncategorized Disclosures: TBD Article Navigation Dr. Nicole Cyrille Superville and Dr. C. Michael Gibson discuss: Demographic Disparities in Tafamidis Treatment and Clinical Outcomes Across the United States Dr. Allen Taylor and Dr. C. Michael Gibson discuss how Heartflow’s Plaque Analysis AI is changing preventative cardiology, risk stratification, and patient management today in practice.
